Neuberger Berman Group LLC Sutro Biopharma, Inc. Transaction History

Neuberger Berman Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $1.14 Million - $2.25 Million	-146,745 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$14.25 - $23.53 $1.06 Million - $1.75 Million	-74,173 Reduced 33.57%	146,745 $2.14 Million
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $101,870 - $135,063	6,035 Added 2.81%	220,918 $4.08 Million
Q2 2021 Aug 13, 2021	BUY	$18.03 - $23.82 $48,212 - $63,694	2,674 Added 1.26%	214,883 $3.99 Million
Q1 2021 May 13, 2021	BUY	$20.29 - $27.54 $1.84 Million - $2.5 Million	90,709 Added 74.66%	212,209 $4.83 Million
Q4 2020 Feb 10, 2021	BUY	$10.16 - $23.98 $1.23 Million - $2.91 Million	121,500 New	121,500 $2.64 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $140M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.